Donghua He

1.0k total citations
59 papers, 796 citations indexed

About

Donghua He is a scholar working on Hematology, Oncology and Molecular Biology. According to data from OpenAlex, Donghua He has authored 59 papers receiving a total of 796 indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Hematology, 28 papers in Oncology and 27 papers in Molecular Biology. Recurrent topics in Donghua He's work include Multiple Myeloma Research and Treatments (25 papers), Protein Degradation and Inhibitors (11 papers) and Peptidase Inhibition and Analysis (8 papers). Donghua He is often cited by papers focused on Multiple Myeloma Research and Treatments (25 papers), Protein Degradation and Inhibitors (11 papers) and Peptidase Inhibition and Analysis (8 papers). Donghua He collaborates with scholars based in China, United States and Croatia. Donghua He's co-authors include Zhen Cai, Jingsong He, Fuming Zi, Xuetao Cao, Taoyong Chen, Yi Li, Yuzhen Wang, Chaofeng Han, Huazhang An and Haibo Liu and has published in prestigious journals such as Blood, Frontiers in Immunology and Advanced Science.

In The Last Decade

Donghua He

49 papers receiving 786 citations

Peers

Donghua He
Yixiang Han China
Christa Pfeifhofer‐Obermair Austria
Ann Biehl United States
Yuhui Liu China
David Bastian United States
Maohua Shi China
Shangbin Yang United States
Hye‐Jwa Oh South Korea
Rhiannon Morris Australia
Sofie Starckx Belgium
Yixiang Han China
Donghua He
Citations per year, relative to Donghua He Donghua He (= 1×) peers Yixiang Han

Countries citing papers authored by Donghua He

Since Specialization
Citations

This map shows the geographic impact of Donghua He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Donghua He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Donghua He more than expected).

Fields of papers citing papers by Donghua He

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Donghua He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Donghua He. The network helps show where Donghua He may publish in the future.

Co-authorship network of co-authors of Donghua He

This figure shows the co-authorship network connecting the top 25 collaborators of Donghua He. A scholar is included among the top collaborators of Donghua He based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Donghua He. Donghua He is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Mingdong, Sheng‐Yu Jin, Xin Fu, et al.. (2025). Activation of Kir4.1 Channels by 2‐D08 Promotes Myelin Repair in Multiple Sclerosis. Advanced Science. 12(34). e02032–e02032. 1 indexed citations
2.
He, Donghua, et al.. (2025). Impact of KIT mutation on efficacy of venetoclax and hypomethylating agents in newly diagnosed acute myeloid leukemia. European journal of medical research. 30(1). 354–354. 3 indexed citations
3.
Zhang, Yongjin, Yanwen Gong, Donghua He, et al.. (2025). A mechanochemical addition/reduction cascade process for the synthesis of dual stereocentered chiral δ-hydroxysulfones. Organic Chemistry Frontiers. 12(15). 4311–4320.
4.
Wang, Chenyun, Yang Yang, Donghua He, et al.. (2024). Survival of Hemodialysis-Dependent Multiple Myeloma Patients and Factors Associated with Dialysis Independence: A Real-World Study in China. Blood. 144(Supplement 1). 6913–6913. 1 indexed citations
5.
He, Jingsong, Wenjun Wu, Xiaoyan Han, et al.. (2023). Outcomes of COVID‐19 in multiple myeloma patients treated with daratumumab. Cancer Science. 115(1). 237–246. 7 indexed citations
6.
Gu, Huiyao, Donghua He, Yi Li, et al.. (2023). Increase of Dnts Correlated with Clinic Outcome after Allogeneic DNT Cells Infusion in r/r AML Patients. Blood. 142(Supplement 1). 6867–6867.
7.
8.
Yue, Xiaoyan, Linlin Huang, Yang Yang, et al.. (2022). High levels of serum IL-10 indicate disease progression, extramedullary involvement, and poor prognosis in multiple myeloma. Journal of Zhejiang University SCIENCE B. 23(11). 968–974. 7 indexed citations
9.
Zheng, Gaofeng, Xiaoyan Han, Yang Li, et al.. (2022). Efficacy of Intermittent, Oral Famciclovir Prophylaxis for Bortezomib-Induced Herpes Zoster in Multiple Myeloma Patients. Frontiers in Oncology. 12. 843032–843032. 5 indexed citations
10.
He, Donghua, Gaofeng Zheng, Jingsong He, et al.. (2021). The Clinical Characteristics and Prognosis of Chinese Patients with Light-Chain Amyloidosis: A Retrospective Multicenter Analysis. Indian Journal of Hematology and Blood Transfusion. 38(3). 444–453. 3 indexed citations
11.
He, Jingsong, Xiaoyan Yue, Donghua He, et al.. (2021). Multiple Extramedullary-Bone Related and/or Extramedullary Extraosseous Are Independent Poor Prognostic Factors in Patients With Newly Diagnosed Multiple Myeloma. Frontiers in Oncology. 11. 668099–668099. 19 indexed citations
12.
He, Jingsong, Donghua He, Xiaoyan Han, et al.. (2020). Bortezomib-Based Regimens for Newly Diagnosed Multiple Myeloma in China: A Report of 12-Year Real-World Data. Frontiers in Pharmacology. 11. 561601–561601. 10 indexed citations
13.
Yan, Haimeng, Mengmeng Dong, Xinling Liu, et al.. (2019). Multiple myeloma cell-derived IL-32γ increases the immunosuppressive function of macrophages by promoting indoleamine 2,3-dioxygenase (IDO) expression. Cancer Letters. 446. 38–48. 41 indexed citations
14.
Yang, Yang, Gang Wang, Wenjun Wu, et al.. (2018). Camalexin Induces Apoptosis via the ROS‐ER Stress‐Mitochondrial Apoptosis Pathway in AML Cells. Oxidative Medicine and Cellular Longevity. 2018(1). 7426950–7426950. 30 indexed citations
15.
He, Jingsong, Qingxiao Chen, Huiyao Gu, et al.. (2018). Therapeutic effects of the novel subtype-selective histone deacetylase inhibitor chidamide on myeloma-associated bone disease. Haematologica. 103(8). 1369–1379. 21 indexed citations
16.
Yang, Li, Jing Chen, Xiaoyan Han, et al.. (2018). Pirh2 mediates the sensitivity of myeloma cells to bortezomib via canonical NF-κB signaling pathway. Protein & Cell. 9(9). 770–784. 15 indexed citations
17.
Wei, Guoqing, Lijun Wang, Hanjin Yang, et al.. (2017). Clinical implications of c-maf expression in plasma cells from patients with multiple myeloma. Experimental Hematology and Oncology. 6(1). 16–16. 4 indexed citations
18.
He, Donghua, Xing Guo, Enfan Zhang, et al.. (2016). Quercetin induces cell apoptosis of myeloma and displays a synergistic effect with dexamethasone in vitro and in vivo xenograft models. Oncotarget. 7(29). 45489–45499. 30 indexed citations
19.
Bao, Hanying, Peilin Lu, Yi Li, et al.. (2011). Triggering of toll-like receptor-4 in human multiple myeloma cells promotes proliferation and alters cell responses to immune and chemotherapy drug attack. Cancer Biology & Therapy. 11(1). 58–67. 31 indexed citations
20.
He, Donghua, Taoyong Chen, Mingjin Yang, et al.. (2010). Small Rab GTPase Rab7b promotes megakaryocytic differentiation by enhancing IL-6 production and STAT3-GATA-1 association. Journal of Molecular Medicine. 89(2). 137–150. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yixiang Han Breakdown of academic impact, for papers by Christa Pfeifhofer‐Obermair Breakdown of academic impact, for papers by Ann Biehl Breakdown of academic impact, for papers by Yuhui Liu Breakdown of academic impact, for papers by David Bastian Breakdown of academic impact, for papers by Maohua Shi Breakdown of academic impact, for papers by Shangbin Yang Breakdown of academic impact, for papers by Hye‐Jwa Oh Breakdown of academic impact, for papers by Rhiannon Morris Breakdown of academic impact, for papers by Sofie Starckx
Rankless by CCL
2026